FR3638M - New drug active on the central nervous system and endowed in particular with psychotonic effect. - Google Patents

New drug active on the central nervous system and endowed in particular with psychotonic effect.

Info

Publication number
FR3638M
FR3638M FR976435A FR976435A FR3638M FR 3638 M FR3638 M FR 3638M FR 976435 A FR976435 A FR 976435A FR 976435 A FR976435 A FR 976435A FR 3638 M FR3638 M FR 3638M
Authority
FR
France
Prior art keywords
psychotonic
endowed
effect
nervous system
central nervous
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR976435A
Other languages
French (fr)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Aventis France
Original Assignee
Roussel Uclaf SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roussel Uclaf SA filed Critical Roussel Uclaf SA
Priority to FR976435A priority Critical patent/FR3638M/en
Application granted granted Critical
Publication of FR3638M publication Critical patent/FR3638M/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/06—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with radicals, containing only hydrogen and carbon atoms, attached to ring carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
FR976435A 1964-05-29 1964-05-29 New drug active on the central nervous system and endowed in particular with psychotonic effect. Expired FR3638M (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR976435A FR3638M (en) 1964-05-29 1964-05-29 New drug active on the central nervous system and endowed in particular with psychotonic effect.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR976435A FR3638M (en) 1964-05-29 1964-05-29 New drug active on the central nervous system and endowed in particular with psychotonic effect.

Publications (1)

Publication Number Publication Date
FR3638M true FR3638M (en) 1965-10-25

Family

ID=8831244

Family Applications (1)

Application Number Title Priority Date Filing Date
FR976435A Expired FR3638M (en) 1964-05-29 1964-05-29 New drug active on the central nervous system and endowed in particular with psychotonic effect.

Country Status (1)

Country Link
FR (1) FR3638M (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0453298A2 (en) * 1990-04-18 1991-10-23 Merck & Co. Inc. Chiral catalysts for reduction of ketones and process for their preparation
US5189177A (en) * 1990-04-18 1993-02-23 Merck & Co., Inc. Chiral boron catalysts for reduction of ketones and process for their preparation
US5264585A (en) * 1990-04-18 1993-11-23 Merck & Co., Inc. Chiral catalysts for reduction of ketones and process for their preparation

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0453298A2 (en) * 1990-04-18 1991-10-23 Merck & Co. Inc. Chiral catalysts for reduction of ketones and process for their preparation
EP0453298A3 (en) * 1990-04-18 1992-07-22 Merck & Co. Inc. Chiral catalysts for reduction of ketones and process for their preparation
US5189177A (en) * 1990-04-18 1993-02-23 Merck & Co., Inc. Chiral boron catalysts for reduction of ketones and process for their preparation
US5264585A (en) * 1990-04-18 1993-11-23 Merck & Co., Inc. Chiral catalysts for reduction of ketones and process for their preparation
EP0668266A1 (en) * 1990-04-18 1995-08-23 Merck & Co. Inc. Chiral catalysts for reduction of ketones and process for their preparation
EP0962451A2 (en) * 1990-04-18 1999-12-08 MERCK & CO. INC. Chiral catalysts for reduction of ketones and process for their preparation
EP0962451A3 (en) * 1990-04-18 2002-07-31 MERCK & CO. INC. Chiral catalysts for reduction of ketones and process for their preparation

Similar Documents

Publication Publication Date Title
FR3715M (en) Improved antithermics and antirheumatic drugs.
FR3816M (en) New drug having in particular a stimulating effect on the central nervous system.
FR3060M (en) New drug endowed in particular with hypocholesterolemic activity.
FR3638M (en) New drug active on the central nervous system and endowed in particular with psychotonic effect.
FR2852M (en) Pharmaceutical preparations acting on the central nervous system.
FR3243M (en) New drug active on the central nervous system and endowed in particular with psychotonic effect.
FR1625M (en) Drug with nutritive and antitoxic action.
Stewart Thucydides, Pausanias, and Alcibiades
FR1515628A (en) Acrylonitrile copolymers
FR3787M (en) New drug endowed in particular with antimitotic activity.
FR3012M (en) New drugs endowed in particular with hypocholesterolemic activity.
FR3375M (en) New drug endowed in particular with antiphlébitic activity.
FR2419M (en) New drugs endowed in particular with stathmokinetic activity.
FR3032M (en) New drugs endowed in particular with antimitotic activity.
FR2652M (en) New drug endowed in particular with stathmokinetic activity.
FR2655M (en) New drug endowed in particular with stathmokinetic activity.
FR2654M (en) New drug endowed in particular with antimitotic activity.
FR2926M (en) New drug endowed in particular with antimitotic activity.
FR2712M (en) New drug endowed in particular with antimitotic activity.
FR2420M (en) New drug endowed in particular with antimitotic activity.
FR2818M (en) New drug endowed in particular with stathmokinetic activity.
FR2731M (en) New drug endowed in particular with antimitotic activity.
FR2994M (en) New drug endowed in particular with antimitotic activity.
FR3180M (en) New drug endowed in particular with antimitotic activity.
FR2782M (en) New drugs that are active on the autonomic nervous system and have anorexigenic and stimulating properties on the central nervous system.